Responses
Poster Presentations
Rheumatoid arthritis - other biologic treatment
SAT0205 Long-term drug survival and causes of discontinuation of subcutaneous abatacept in rheumatoid arthritis: 32-month results from a prospective cohort study
Compose a Response to This Article
Other responses
No responses have been published for this article.